# GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT

> **NCT03911037** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 70 (estimated)

## Conditions studied

- Decompensated Cirrhosis of Liver

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03911037
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-04
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911037, "GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03911037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*